USFDA approves Genentech’s Vabysmo to treat causes of vision loss
Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet AMD and DME, with flexible dosing regimens based on patient need
Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet AMD and DME, with flexible dosing regimens based on patient need
ABDM is a digital framework that will connect patients, doctors and other healthcare stakeholders nationwide to facilitate safe and secure movement of health information
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
The aim is to strengthen industry-academia cooperation
The new centre will comprise a team of 50 highly experienced specialists
It would be the first protein-based alternative available in Israel
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
Subscribe To Our Newsletter & Stay Updated